Research use only · third-party COA for every lot support@retatrutide-peptide.info
Retatrutide-Peptide.info

Store

Order retatrutideBasketLab reportsWholesale

Start here

About retatrutideBenefitsResultsReviewsFDA status

Protocols

Dosage chartCalculatorReconstitutionInjectionHalf-lifeStacks

Safety

Side effectsFor womenBlood sugarMuscle

Compare

vs Tirzepatidevs Semaglutidevs other GLP-1s

Buying

Where to buyPriceCompoundedVendorsOral form

Company

About usReview boardContent standardsSourcesHelp
Pricing

Retatrutide pricing and monthly expenses

A clear examination of retatrutide pricing, the typical monthly expense, what is covered, and why compounded costs differ from branded GLP-1 medications.

Chart comparing retatrutide with single and dual agonists, relevant to value and pricing comparisons
What the price includes relative to other agonist options.

When considering treatment costs, the simple response to 'how much does retatrutide cost' is: it varies. In the US, retatrutide pricing isn't set by a single manufacturer's list price, because retatrutide is an investigational not FDA-approved peptide obtainable only via compounding pharmacies with a licensed provider. As a typical example, a full monthly plan for compounded retatrutide generally falls within the $179, $399 per month range. These are market observations, not quotes, and reported prices differ by program, dosage in milligrams, pharmacy, and bundled services.

  • Representative range: Around $179 or $399 per month, all-inclusive (example, not a guaranteed price)
  • Insurance: Not covered by insurance, compounded, and not FDA-approved
  • Billing: Billing is usually per vial or per month; many programs do not require long-term commitments
  • Main cost drivers: Dosage (mg), compounding, provider supervision, shipping

Monthly retatrutide cost: an indication of realistic pricing

Most people searching for retatrutide price per month are evaluating telehealth services, not purchasing a raw ingredient. Since retatrutide is typically increased gradually over several weeks, the monthly expense during the initial phase (low dose) is often less than at a higher maintenance dose. That's why a single 'retatrutide cost per month' figure can be misleading unless it specifies the dosage it assumes.

How dosage level impacts the price

Compounded peptides are priced largely based on the total milligrams dispensed. A low starting dose requires less active substance than a higher maintenance dose, so retatrutide cost tends to increase as the dose escalates in trial protocols. A reliable program will list the price at each dose level instead of only promoting the lowest entry cost. For a clearer understanding of dose progression, our article on what this molecule is explains the titration concept in straightforward terms.

Per vial versus monthly subscription billing

Pricing is typically arranged in one of two ways. Some pharmacies charge per vial (requiring reorders when stock runs low), while telehealth programs quote a monthly A figure that spreads the vial, visit, and shipping across the month. Neither is automatically cheaper; the per-vial model can look lower until you add the visit and shipping that a monthly bundle already includes.

What drives retatrutide price

Knowing the components makes it easier to judge whether a retatrutide peptide price is fair or suspiciously low. A legitimate program price reflects four things working together.

The four main cost components

  1. Medication (the compounded peptide): Priced by milligrams; the largest single driver, and it grows as the dose increases.
  2. Provider oversight: The licensed clinician who evaluates eligibility, prescribes, and monitors the patient. This is a real medical service, not a markup.
  3. Pharmacy compounding & supplies: Sterile compounding, the vial, and often syringes, alcohol swabs, and sharps guidance.
  4. Shipping & cold handling: Temperature-controlled, tracked delivery adds cost that a bare 'research chemical' listing skips.

When a listing advertises unusually cheap retatrutide, the price is almost always low because one or more of these components has been removed. Most often the provider oversight and the sterile, verified supply chain.

Why insurance won't cover retatrutide

Many individuals are surprised when they see the monthly cost of retatrutide without insurance. Health insurers generally only pay for FDA-approved medications prescribed for their approved indications. Retatrutide is still under investigation, and compounded versions offered through telehealth are not FDA-approved products. As a result, insurance plans and most pharmacy benefit managers refuse coverage, and no manufacturer copay cards exist.

Budgeting implications

In reality, you should consider the price of retatrutide in the USA as a full cash outlay. Don't expect a deductible or copay to reduce the amount as it might for an approved medication, though some people may be able to use HSA or FSA funds for qualifying telehealth expenses, which is worth confirming with your own plan.

How retatrutide's price compares to brand-name GLP-1 drugs

A common question is how the cost of retatrutide compares to that of tirzepatide. Brand-name GLP-1 medications such as tirzepatide (Zepbound/Mounjaro) and semaglutide (Wegovy/Ozempic) have list prices that can exceed a thousand dollars per month without insurance, although those with coverage may pay far less. Compounded retatrutide usually has a lower cash price because it avoids the branded supply chain, but it also lacks FDA approval and has no path to insurance reimbursement.

The honest comparison

As a result, a compounded peptide might look less expensive than the cash price of a branded drug while actually costing more than that same branded drug after when you have good insurance coverage. Direct comparisons are rarely simple. For a more detailed side-by-side of efficacy and trade-offs, see our breakdown of how retatrutide cost and effects compare to tirzepatide and review realistic reported outcomes before you decide what value means for you.

A note on "value"

The lowest price isn't always the best value. Here, value means a verified supply, a licensed provider managing your care, and a price you fully understand. When you're ready to compare a program's dose-by-dose pricing, you can buy retatrutide online only after a legitimate telehealth evaluation, never from an anonymous seller.

Retatrutide cost FAQ

What is the monthly cost of retatrutide?

As an illustrative example, all-inclusive compounded programs commonly range from $179 to $399 per month, but this varies widely by provider, dose, and pharmacy. These figures are market observations for illustration, not quotes.

What will retatrutide cost without insurance?

You should expect to pay the full out-of-pocket price, since retatrutide lacks FDA approval and isn't covered by insurance. No manufacturer copay cards exist to reduce it, so the quoted cash price is typically what you'll pay.

Why is some retatrutide so cheap online?

Extremely low-priced listings are usually 'research chemical' products sold without a licensed provider, verified compounding, or included supplies. The low price reflects what has been removed, not a genuine discount, and it comes with real safety and legal risks.

Is retatrutide priced lower than tirzepatide?

Compounded retatrutide is often advertised at a cost below the cash price for branded tirzepatide, yet tirzepatide could be considerably more affordable for insured patients. These two aren't alike in terms of comparison, and only one carries FDA approval.

Is the charge per vial or through a monthly subscription?

Both billing structures exist. Some pharmacies bill per vial, while telehealth services quote a monthly rate. Many programs don't require long-term subscription commitments, but it's wise to verify billing details before placing an order.

Can HSA or FSA funds be used for payment?

Some individuals use HSA or FSA money for eligible telehealth expenses, though this isn't assured for an investigational compounded item. Check with your plan administrator beforehand.

Retatrutide vial
Retatrutide
Research-grade · COA per lot
$125.00

Sources & references

Factual assertions on this page align with primary literature, trial registries, and regulators listed below. See our editorial policy regarding our sourcing and review methods.

  1. U.S. FDA: Human Drug Compounding Statutes (sections 503A and 503B). View source
  2. NIH / NIDDK: Prescription Drugs to Tackle Overweight & Obesity. View source
Retatrutide vial
Retatrutide98%+ purity · third-party tested
$125.00